JAC Advance Access published online on January 16, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh083
© 2004 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original article
1 Institut für
Medizinische Mikrobiologie und Immunologie der Universität
Bonn, D-53105 Bonn, Germany;
* Corresponding author. E-mail: sahl{at}mibi03.meb.uni-bonn.de.
Received 22 September 2003
; revised 19 November 2003
; accepted 20 November 2003
Objectives: Increasing resistance
of pathogenic bacteria to antibiotics is a severe problem in health
care and has intensified the search for novel drugs. Cationic antibacterial
peptides are the most abundant antibiotics in nature and have been
frequently proposed as new anti-infective agents. Here, a group
of diastereomeric (containing D- and L-amino
acids) peptides is studied regarding their potency against multiply
resistant clinical isolates and their modes of action against Gram-positive
cocci. Methods: MIC determinations and chequerboard
titrations followed established procedures. Mode of action studies
included killing kinetics and a series of experiments designed to
characterize the impact of the diastereomeric peptides on bacterial
membranes. Results: The tested diastereomers displayed
high antimicrobial and broad spectrum activity with amphipathic-2D
being the most active peptide. Synergic activities were observed
with individual strains. Mode of action studies clearly demonstrated
that the cytoplasmic membrane is a primary target for the peptides
and that membrane disruption constitutes a significant bactericidal
activity for the major fraction of a bacterial population. However,
depending on the indicator strain, the results also suggest that
additional molecular events contribute to the overall activity.
Keywords: synergic activities, membrane permeabilization,
intracellular targets
In vitro activity and mode of
action of diastereomeric antimicrobial peptides against bacterial
clinical isolates
2 Department
of Biological Chemistry, The Weizmann Institute of Science, Rehovot,
76100 Israel
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. L. Mangoni, R. F. Epand, Y. Rosenfeld, A. Peleg, D. Barra, R. M. Epand, and Y. Shai Lipopolysaccharide, a Key Molecule Involved in the Synergism between Temporins in Inhibiting Bacterial Growth and in Endotoxin Neutralization J. Biol. Chem., August 22, 2008; 283(34): 22907 - 22917. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Chongsiriwatana, J. A. Patch, A. M. Czyzewski, M. T. Dohm, A. Ivankin, D. Gidalevitz, R. N. Zuckermann, and A. E. Barron Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides PNAS, February 26, 2008; 105(8): 2794 - 2799. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Pag, M. Oedenkoven, V. Sass, Y. Shai, O. Shamova, N. Antcheva, A. Tossi, and H.-G. Sahl Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an {alpha}-helical 'sequence template' J. Antimicrob. Chemother., February 1, 2008; 61(2): 341 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Rosenfeld, D. Barra, M. Simmaco, Y. Shai, and M. L. Mangoni A Synergism between Temporins toward Gram-negative Bacteria Overcomes Resistance Imposed by the Lipopolysaccharide Protective Layer J. Biol. Chem., September 29, 2006; 281(39): 28565 - 28574. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Chatterjee, G. A. Somerville, C. Heilmann, H.-G. Sahl, H. H. Maurer, and M. Herrmann Very Low Ethanol Concentrations Affect the Viability and Growth Recovery in Post-Stationary-Phase Staphylococcus aureus Populations Appl. Envir. Microbiol., April 1, 2006; 72(4): 2627 - 2636. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. Sahl, U. Pag, S. Bonness, S. Wagner, N. Antcheva, and A. Tossi Mammalian defensins: structures and mechanism of antibiotic activity J. Leukoc. Biol., April 1, 2005; 77(4): 466 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Braunstein, N. Papo, and Y. Shai In Vitro Activity and Potency of an Intravenously Injected Antimicrobial Peptide and Its DL Amino Acid Analog in Mice Infected with Bacteria Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3127 - 3129. [Abstract] [Full Text] [PDF] |
||||





